Cyclobenzaprine Hydrochloride
Product Images NDC 58517-080

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 58517-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by New Horizon Rx Group, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Flexeril (cyclobenzaprine HCl) Structural Formula Illustration (E8799c4d Figure 01)

Flexeril (cyclobenzaprine HCl) Structural Formula Illustration (E8799c4d Figure 01)
Chemical structure diagram of Cyclobenzaprine Hydrochloride, showing a tricyclic ring system with an attached side chain including an amine functional group and a hydrochloride component.*
FDA Label Image

E8799c4d-figure-02 (E8799c4d Figure 02)

E8799c4d-figure-02 (E8799c4d Figure 02)
Label for Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg strength, in a bottle of 30 tablets. The label shows the NDC 58517-080-30 and indicates the product is prescription only (Rx Only). The labeler is New Horizon Rx Group, LLC, located in Kenner, LA. Storage and dispensing instructions and a barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.